To register for any or all of the 2010 webinars, go to http://hemacare.webex.com or email TAinfo@hemacare.com.

All webinars will begin at 12 PM PST/3 PM EST every 3rd Tuesday of the month; April - November.

Webinars (topics are subject to change)

April 20
Therapeutic Apheresis Support for Incompatible Kidney Transplantation

• Review the rationale for performing incompatible kidney transplants
• Describe the role of therapeutic apheresis in ABO incompatible kidney transplantation
• Understand the use of therapeutic apheresis in HLA incompatible kidney transplantation

May 18
Cellular Therapies - Current Insights

• Highlight the advances and challenges in hematopoietic progenitor cell (HPC) collection - apheresis versus marrow HPC products for hematopoietic stem cell transplantion (HCT)
• Discuss the role of preCD34 counts and/or collection efficiency for initiating HPC collections
• Discuss the role of therapeutic apheresis procedures in the management of posttransplantion complications

June 15
Applications of Therapeutic Apheresis in Hematology and Oncology

• Overview of apheresis
• Indications for therapeutic apheresis in hematology and oncology
• Discuss new cellular therapies
• The safety profile of therapeutic apheresis

July 20
Photopheresis - Current Insights

• Cutaneous T-Cell Lymphoma (CTCL)
• Graft versus Host Disease (GvHD)
• Solid Organ Transplant Rejection

August 17
Clinical Applications of Therapeutic Apheresis in Neurology

• Overview of therapeutic apheresis
• Indications for therapeutic apheresis in neurology
• Therapeutic plasma exchange vs. IVIg
• The safety profile of therapeutic apheresis

September 21
Clinical Applications of Red Blood Cell Exchange (RBCX) for Sickle Cell Disease

• Define apheresis
• Discuss rationale for use of RBCX
• Explain the potential benefits in sickle cell disease
• Complications of treatment

October 19
Clinical Applications of LDL-Apheresis Therapy

• Define the problem of treatment for familial hypercholesterolemia and patients who are refractory or intolerant to diet and drug therapy
• Discuss recommended LDL levels for high risk individuals with regard to arterio sclerotic heart disease
• Discuss existing current extracorporeal systems for reduction of LDL cholesterol
• Describe observed LDL reduction with these extracorporeal systems
• Review clinical studies showing efficacy for LDL apheresis
• Review tolerability of patients for these procedures

November 16
Guidelines for the Medical Supervision of Therapeutic Apheresis

• Discuss technical considerations and patient assessment
• Discuss some differences between dialysis and plasma exchange
• Explain how to write orders for fluid replacement
• Understand issues of anticoagulation in therapeutic apheresis
• Discuss complications of therapeutic apheresis